CardioComm Solutions Inc. (EKG) — Capital Reinvestment Ratio

Latest as of September 2022: 0.20x

CardioComm Solutions Inc. (EKG) has a Capital Reinvestment Ratio of 0.20x as of September 2022, meaning it reinvests 0% of its operating cash flow (CA$39.73K) in capital expenditures (CA$7.99K). Check EKG intangible-adjusted equity ratio to evaluate the tangible quality of the company's equity base.

Capital Reinvestment Ratio

0.20x
Capex / Operating Cash Flow

Operating Cash Flow

CA$39.73K
CAD

Capital Expenditures

CA$7.99K
CAD

Data as of

Sep 2022
Most recent filing

CardioComm Solutions Inc. Capital Reinvestment Ratio (2020–2022)

This chart tracks CardioComm Solutions Inc.'s Capital Reinvestment Ratio across 2 annual periods. For the full cash flow conversion analysis, see cash flow conversion of CardioComm Solutions Inc..

Annual Capital Reinvestment Ratio for CardioComm Solutions Inc. (2020–2022)

Year-by-year Capital Reinvestment Ratio for CardioComm Solutions Inc. from 2020 to 2022. See EKG cash flow after capex ratio to measure how efficiently the company converts operating cash flow to free cash.

Year Reinvestment Ratio Operating CF (CAD) Capital Expenditures YoY Change
2022 0.04x CA$54.52K CA$2.20K ▼ -88.1%
2020 0.34x CA$39.40K CA$13.37K —
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow